Health Canada drug identification number

DIN 02403188 — CISPLATIN INJECTION 1.0 MG

CISPLATIN INJECTION is a solution of Cisplatin marketed by TEVA CANADA LIMITED. The full Cisplatin monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.

DIN
02403188
Brand name
CISPLATIN INJECTION
Active ingredient
Cisplatin
Strength
1.0 MG
Dosage form
SOLUTION
Route
INTRAVENOUS
Manufacturer
TEVA CANADA LIMITED
Health Canada status
MARKETED
Drug class
Platinum-based alkylating antineoplastic agent

Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.

Other Cisplatin products

DINBrandStrengthFormManufacturerStatus
02126613 CISPLATIN INJECTION BP 1 MG SOLUTION PFIZER CANADA ULC MARKETED
02536285 CISPLATIN INJECTION BP 1 MG SOLUTION HIKMA CANADA LIMITED MARKETED
02355183 CISPLATIN INJECTION, BP 1 MG SOLUTION ACCORD HEALTHCARE INC MARKETED

Rejoining the server...

Rejoin failed... trying again in seconds.

Failed to rejoin.
Please retry or reload the page.

The session has been paused by the server.

Failed to resume the session.
Please retry or reload the page.